PharmaCyte Biotech Inc (PMCB)

[Peacefulwendy]

"The research team hopes their pancreatic treatment will be effective in reducing malignant ascites’ fluid accumulation in colon cancer patients, while reducing the number of fluid withdrawals that patients must tolerate. The goal is to help patients who suffer from ascites fluid accumulation, a major problem for patients suffering with abdominal cancer which causes pain and other serious complications. When ascites’ fluid levels get to a certain amount, they must be removed — a costly and uncomfortable procedure for patients. "

The human trials will start in 3Q. Issues with the title must be taken up with the author, Daniela Samedo. However, I understand exactly what she means by her titlle, as I think most people do...

Pancreatic Cancer Drug Works Against Accumulation of Malignant Ascites Fluid in Colon Cancer Patients

Cell in a Box(R) technology...

http://coloncancernewstoday.com/2015/04/13/pancreatic-cancer-drug-works-against-accumulation-of-malignant-ascites-fluid-in-colon-cancer-patients/